Respiratory Illness season is right around the corner and experts are urging parents to take action to protect their newborns ...

Adults who are at risk of severe RSV are 75 years or older. Also, people between 60 and 74 years old who have chronic health ...

In most cases, adequate hydration and over-the-counter pain relievers can help manage your symptoms during the week or two it ...

EDP-323 is an investigational inhibitor of Respiratory Syncytial Virus (RSV), currently showing promising results in Phase 2a ...

U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age group and ...

Flu, COVID-19 and RSV are predicted to cause about as many hospitalizations as last year. Houston experts offer tips for ...

Particularly if you tend not to have vaccine side effects, getting routine shots in one go may be a convenient option.

GSK announced on Tuesday that a single dose of its Arexvy vaccine against respiratory syncytial virus (RSV) was 43.3% ...

As the days grow cooler, families across Utah are reminded that respiratory viruses, particularly Respiratory Syncytial Virus ...

GSK said on Tuesday that its Arexvy respiratory syncytial virus vaccine was 43.3% effective in preventing severe illness in ...

The public, by and large, has not been on board with immunizations in the aftermath of the pandemic, despite public health ...

Low uptake in the RSV and COVID vaccine markets is not surprising, an analyst says, and could mean weak earnings for ...